Creo Medical Group Future Growth
Future criteria checks 1/6
Creo Medical Group is forecast to grow earnings and revenue by 69.7% and 9% per annum respectively. EPS is expected to grow by 71.3% per annum. Return on equity is forecast to be -1.8% in 3 years.
Key information
69.7%
Earnings growth rate
71.3%
EPS growth rate
Medical Equipment earnings growth | 22.9% |
Revenue growth rate | 9.0% |
Future return on equity | -1.8% |
Analyst coverage | Low |
Last updated | 07 Oct 2024 |
Recent future growth updates
Recent updates
Creo Medical Group PLC (LON:CREO) Screens Well But There Might Be A Catch
Sep 19Market Cool On Creo Medical Group PLC's (LON:CREO) Revenues Pushing Shares 26% Lower
Mar 02Revenues Tell The Story For Creo Medical Group PLC (LON:CREO) As Its Stock Soars 29%
Dec 29Is Creo Medical Group (LON:CREO) Weighed On By Its Debt Load?
Oct 06Creo Medical (LON:CREO) Is In A Good Position To Deliver On Growth Plans
Feb 03How Many Creo Medical Limited (LON:CREO) Shares Do Institutions Own?
Dec 09Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 41 | -3 | -14 | -13 | 2 |
12/31/2025 | 38 | -6 | -16 | -15 | 3 |
12/31/2024 | 37 | -16 | -2 | -16 | 3 |
6/30/2024 | 30 | -22 | -22 | -20 | N/A |
3/31/2024 | 31 | -22 | -22 | -21 | N/A |
12/31/2023 | 31 | -22 | -23 | -22 | N/A |
9/30/2023 | 30 | -23 | -24 | -22 | N/A |
6/30/2023 | 29 | -25 | -25 | -23 | N/A |
3/31/2023 | 28 | -26 | -27 | -24 | N/A |
12/31/2022 | 27 | -27 | -28 | -25 | N/A |
9/30/2022 | 27 | -28 | -33 | -27 | N/A |
6/30/2022 | 26 | -28 | -38 | -30 | N/A |
3/31/2022 | 26 | -26 | -35 | -28 | N/A |
12/31/2021 | 25 | -25 | -32 | -26 | N/A |
9/30/2021 | 24 | -23 | -26 | -22 | N/A |
6/30/2021 | 22 | -21 | -19 | -19 | N/A |
3/31/2021 | 16 | -21 | -18 | -18 | N/A |
12/31/2020 | 9 | -20 | -17 | -16 | N/A |
9/30/2020 | 5 | -19 | -17 | -16 | N/A |
6/30/2020 | 0 | -17 | -17 | -16 | N/A |
3/31/2020 | 0 | -17 | -15 | -14 | N/A |
12/31/2019 | 0 | -16 | -13 | -12 | N/A |
6/30/2019 | 0 | -13 | -14 | -13 | N/A |
3/31/2019 | 0 | -12 | -12 | -11 | N/A |
12/31/2018 | N/A | -10 | -10 | -10 | N/A |
12/31/2017 | 0 | -8 | N/A | -9 | N/A |
9/30/2017 | 0 | -8 | N/A | -8 | N/A |
6/30/2017 | N/A | -8 | N/A | -7 | N/A |
6/30/2016 | 1 | -5 | N/A | -5 | N/A |
2/29/2016 | 1 | -3 | N/A | -3 | N/A |
2/28/2015 | N/A | -2 | N/A | -2 | N/A |
2/28/2014 | 1 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CREO is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: CREO is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: CREO is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: CREO's revenue (9% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: CREO's revenue (9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CREO is forecast to be unprofitable in 3 years.